JP Morgan Chase’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-96,200
Closed -$64K 7474
2022
Q4
$64K Sell
96,200
-16,400
-15% -$8.64K ﹤0.01% 5531
2022
Q3
$608K Sell
112,600
-13,000
-10% -$6.74K ﹤0.01% 4333
2022
Q2
$64K Sell
125,600
-1,000
-0.8% -$489 ﹤0.01% 5584
2022
Q1
$67K Buy
126,600
+52,500
+71% +$30.4K ﹤0.01% 5683
2021
Q4
$46K Sell
74,100
-1,800
-2% -$2.03K ﹤0.01% 5988
2021
Q3
$115K Sell
75,900
-1,400
-2% -$2.27K ﹤0.01% 5504
2021
Q2
$132K Sell
77,300
-200
-0.3% -$345 ﹤0.01% 5442
2021
Q1
$132K Buy
77,500
+10,000
+15% +$22.4K ﹤0.01% 5307
2020
Q4
$115K Buy
67,500
+20,500
+44% +$20.4K ﹤0.01% 4973
2020
Q3
$35K Buy
47,000
+29,600
+170% +$23.4K ﹤0.01% 5041
2020
Q2
$15K Sell
17,400
-61,642
-78% -$31.6K ﹤0.01% 5081
2020
Q1
$21K Sell
79,042
-16,000
-17% -$6.37K ﹤0.01% 4945
2019
Q4
$47K Buy
+95,042
New +$58.3K ﹤0.01% 5151

Other funds holding TMDI

JP Morgan Chase's TMDI Position: Q1 2023 in Review

JP Morgan Chase sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 96,200 shares — an estimated $64K sold.

JP Morgan Chase first reported a position in TMDI in Q4 2019 and held it in 13 quarters. The position peaked at $608K in Q3 2022. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • JP Morgan Chase reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 96,200 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $64K.
  • JP Morgan Chase first reported a position in Titan Medical Inc. Ordinary Shares in Q4 2019 and held it in 13 quarters.
  • JP Morgan Chase's Titan Medical Inc. Ordinary Shares position peaked at $608K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.